Elevated circulating concentrations of the hormone gastrin contribute to the development of gastric adenocarcinoma and types-1 and 2 gastric neuroendocrine tumors (NETs). Here, GAST is linked to gastric neuroendocrine tumor, well differentiated, low or intermediate grade.